Topic: Advanced Therapies – RNA Therapeutics: RigImmune
Host: James G. Boyle, PhD, Executive Director, Faculty Entrepreneurship & Venture Development Yale Office of Cooperative Research
Moderator: Roy Herbst, MD, PhD: Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director, Translational Science
• Anna Marie Pyle, PhD, Co-Founder, RIGImmune, Inc.. Sterling Professor of Molecular, Cellular & Developmental Biology; Investigator Howard Hughes Med Inst; Prof Chemistry
• Akiko Iwasaki, PhD, Co-Founder, RIGImmune, Inc.. Waldemar Von Zedtwitz Professor of Immunobiology and Molecular, Cellular and Developmental Biology and Professor of Epidemiology (Microbial Diseases); Professor of Molecular Cellular and Developmental Biology; Investigator, Howard Hughes Medical Institute
• Marty Driscoll, Executive Chair RIGImmune, Inc.
• Donald Corcoran, Advisor: Business Development, RIGImmune, Inc.